A 68-year-old man died a few days after catheter ablation of drug-resistant, monomorphic ventricular tachycardia (VT) complicated with cardiac sarcoidosis. The diagnosis of mitral isthmus VT was made from electrophysiological observations, including electro-anatomical activation and voltage map, pace-mapping, entrainment mapping and ablation outcome. On autopsy of the heart, sarcoidic lesion with scattered fibrous tissue in the mitral isthmus was non-transmural, and the surviving myocardium serving as the reentry circuit in the endomyocardium was isolated from the adjacent viable epimyocardium, enabling the sustenance of macroreentry across the mitral isthmus. Non-transmural lesions produced by RF delivery created a barrier sufficient to interrupt the myocardial bundles located in the mitral isthmus, eliminating the mitral isthmus VT.
Introduction
Sarcoidosis is a multisystem granulomatous disease of unknown etiology. Cardiac involvement may occur in as many as more than 50% of patients in Japan (1) . Sustained ventricular tachycardia (VT), one of the manifestations of cardiac sarcoidosis, occurs frequently, of which the most common mechanism is presumed to be reentry probably due to the slow conduction caused by myocardial scar tissue (2, 3) . Recently, some studies have reported the effectiveness of catheter ablation of VT complicated with cardiac sarcoidosis refractory to medical therapy (4, 5) . However, descriptions of histopathologic examinations of the origin of the VT complicated with cardiac sarcoidosis, successfully ablated are limited to case reports (5, 6) . Furthermore, although the mitral isthmus is a well-known critical region of slow conduction in some patients presenting with VT after healed myocardial infarction (7) (8) (9) (10) , there is no report of mitral isthmus VT complicated with cardiac sarcoidosis. We describe a case of mitral isthmus VT complicated with cardiac sarcoidosis, treated with radiofrequency (RF) ablation, followed by autopsy of the heart, and discuss the pathological characteristics of the origin of the VT and their implications for RF ablation. QRS morphology (VT1), and another with right BBB and inferior axis QRS morphology (VT2) were clinically documented. Left ventriculography showed severe, diffuse hypokinesia and a left ventricular ejection fraction of 28.7%. There was no clinical evidence of extra-cardiac disease.
Electrophysiological study and catheter ablation
Although the patient suffered from pneumonia, catheter ablation was performed due to frequent episodes of VT which were uncontrollable with several antiarrhythmic drugs. Using a CARTO X-P TM electro-anatomical mapping system (Biosense-Webster, Diamond Bar, CA), we identified a 32.3 mm × 26.1 mm low voltage area (defined as bipolar electrograms <0.3 mV) during sinus rhythm at the base of the left ventricular postero-lateral endocardial surface (Fig. 1A) . A QRS resembling the morphology of VT1 or VT2 was produced when pacing along the posterior, postero-lateral and lateral wall adjacent to the mitral annulus ( Fig. 2) , suggesting the presence of a large zone of slow conduction with multiple exits, ranging from the posterior wall to lateral wall, adjacent to the mitral annulus. VT1 and VT2 were both inducible with programmed ventricular stimulation, though only VT1 was sufficiently sustained to allow the recording of an electro-anatomical activation map, which revealed the site of the earliest ventricular activation at the edge of the low voltage area, near the postero-lateral mitral annulus (Fig. 1B) . Entrainment pacing during VT1, adjacent to the mitral annulus, where a low-amplitude, early diastolic potential (DP) was detected, was associated with concealed entrainment and a long spike-QRS delay, equal to the DP-QRS interval, and the difference between a postpacing interval (PPI) of the DP and the tachycardia cycle length was less than 30 ms, suggesting that the mitral isthmus was the critical pathway of the reentrant circuit (Fig. 3) . Moreover, entrainment pacing during VT1, approximately 1 cm away from the mitral annulus, was associated with constant fusion, with a PPI nearly equal to the tachycardia cycle length, consistent with an outer loop of the reentrant circuit. Using an 8F Thermocool TM , irrigated tip ablation catheter (Biosense-Webster), a 45-second RF application at a maximum power of 30 W and maximum temperature of 43°delivered at the mitral annulus, terminated VT1, 17 seconds after the onset of RF delivery. A total of 18 additional linear and crosswise RF applications, representing a total of 25,457 J, were delivered along the mitral annulus in the low voltage area (Fig. 1A) , eliminating the inducibility of VT1 and VT2.
The patient, however, died of sepsis resulting from drugresistant, severe pneumonia, which was not associated with the ablation procedure, 16 days after the ablation procedure, and a post mortem examination of the heart was performed.
Post mortem examination
The heart was autopsied and fixed in 10% formalin within 5 hours of death. The weight of the heart was 520 g. The left ventricle was dissected along the lateral wall to expose the ablation region (Fig. 1C) . Visual inspection revealed no left ventricular dilatation and the presence of a 4.0×2.5 cm lateral aneurysm, with a smooth and whitish endocardial surface (Fig. 1C) . The aneurysm was sectioned transmurally (Fig. 1B) , perpendicular to the mitral annulus, and divided into anterior (Fig. 4A and B) , mid ( Fig. 4C and D) and posterior ( Fig. 4E and F) myocardial blocks, which were stained with Masson trichrome, and processed for standard microscopic analyses.
Microscopic examination of LV free wall near the aneurysm revealed ghosts of multinucleated giant cells with the infiltration of inflammatory leukocytes, consistent with the lesion of cardiac sarcoidosis (Fig. 1D) . By light microscopy, the sarcoidic lesion with scattered fibrous tissue was mostly confined within 2/3 of the endomyocardium, though it reached the epicardium in some areas (Fig. 4D, E and F) , not consistent with an ischemic injury. Likewise, the sarcoidic lesion immediately below the mitral annulus corresponding to the successful ablation site was non-transmural, where neither multinucleate giant cells nor inflammatory leukocytes were observed. The electro-anatomical area of low voltage corresponded with the sarcoidic lesion. Since complete revascularization with coronary artery bypass graft surgery had been performed for ischemic heart disease with-out healed myocardial infarction, non-aneurysmal LV lesion exhibiting severe hypokinesia might also be caused by sarocid lesion. The region of ablation was visible as 3, discontinuous linear hemorrhagic endocardial areas inside the aneurysm, including 1) a line along the mitral annulus, 2) a parallel line approximately 1 cm away from the mitral annulus, and 3) a line perpendicular to the mitral annulus. The ablated area measured 25×20 mm on the endocardial surface and it was approximately 4 mm deep, except in the center of the aneurysm, where the lesion was transmural.
Discussion
In the present case, the diagnosis of mitral isthmus VT was based on the electrophysiological observations made in the area of the sarcoidic lesion, between the mitral annulus and the left postero-lateral aneurysm (mitral isthmus), including electro-anatomical activation and voltage map, pacemapping, entrainment mapping and ablation outcome (7) (8) (9) (10) .
Although the pathological substrate of VT complicating a healed MI has been well characterized (6, 11) , the human pathology of mitral isthmus responsible for VT in a patient with non-ischemic cardiomyopathy remains limited. Matsuyama et al reported the presence of isolated myocardial bundles running along the annulus, which might have been the arrhythmogenic substrate, in a patient with mitral isthmus VT associated with idiopathic dilated cardiomyopathy (12). Scanavacca et al described the presence of tissue surviving between the infero-lateral scar of the left ventricle and the mitral annulus, in a patient presenting with mitral isthmus VT associated with Chagas' disease (13) . In the present case, it is noteworthy that the sarcoidic lesion in the mitral isthmus was characterized by non-transmural lesions and surviving myocardium in the scar, confined to the subendocardium. The surviving myocardium, acting as the reentrant substrate in the endomyocardium, was probably isolated from the adjacent viable epimyocardium, enabling the sustenance of macroreentry across the mitral isthmus. Thus, the non-transmural lesions produced by RF ablation were sufficient to interrupt the myocardial bundles located in the mitral isthmus, and eliminate the VT. To the best of our knowledge, this is the first description of the pathology of a human mitral isthmus associated with VT complicated with cardiac sarcoidosis.
In summary, the present case report describes the histopathology of the mitral isthmus underlying VT associated with cardiac sarcoidosis. The sarcoidic lesion in the mitral isthmus was characterized by non-transmural lesions; and the non-transmural lesions produced by RF delivery were sufficient to interrupt the myocardial bundles located inside the mitral isthmus, eliminating the mitral isthmus VT.
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